Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.31 $4.00 Thursday, 9th May 2024 CYCC stock ended at $2.31. This is 0.431% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 14.48% from a day low at $2.27 to a day high of $2.60.
90 days $1.31 $4.00
52 weeks $1.31 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Jan 03, 2017 $5.27 $5.48 $5.10 $5.47 137 581
Dec 30, 2016 $5.07 $5.29 $4.97 $5.29 99 998
Dec 29, 2016 $5.24 $5.71 $4.95 $5.13 569 438
Dec 28, 2016 $5.02 $6.18 $4.69 $5.37 2 791 961
Dec 27, 2016 $4.02 $5.80 $3.95 $5.18 2 474 263
Dec 23, 2016 $3.94 $4.18 $3.80 $3.95 60 161
Dec 22, 2016 $3.97 $4.10 $3.94 $4.00 39 215
Dec 21, 2016 $4.03 $4.19 $3.97 $4.02 36 975
Dec 20, 2016 $4.10 $4.14 $3.99 $4.06 31 912
Dec 19, 2016 $4.07 $4.15 $3.93 $4.06 32 838
Dec 16, 2016 $4.03 $4.37 $3.96 $4.05 73 923
Dec 15, 2016 $3.95 $4.15 $3.95 $4.00 39 006
Dec 14, 2016 $3.76 $4.11 $3.71 $4.11 27 960
Dec 13, 2016 $3.89 $3.97 $3.79 $3.79 39 906
Dec 12, 2016 $3.98 $4.03 $3.81 $3.82 58 260
Dec 09, 2016 $4.10 $4.30 $4.00 $4.00 66 225
Dec 08, 2016 $4.07 $4.25 $3.96 $4.12 60 550
Dec 07, 2016 $4.25 $4.51 $4.03 $4.06 53 961
Dec 06, 2016 $4.20 $4.34 $4.09 $4.17 85 585
Dec 05, 2016 $4.03 $4.33 $4.01 $4.31 47 661
Dec 02, 2016 $4.23 $4.30 $3.95 $4.06 63 627
Dec 01, 2016 $4.50 $4.71 $3.95 $4.17 135 344
Nov 30, 2016 $4.12 $4.38 $3.85 $3.94 74 768
Nov 29, 2016 $4.24 $4.30 $4.01 $4.06 67 351
Nov 28, 2016 $4.29 $4.32 $4.23 $4.32 38 231
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT